Karin Schmitt
Directeur des opérations chez Mursla Ltd.
Profil
Karin Schmitt is a Chief Operating Officer at Mursla Ltd.
She previously worked as a Genomics Director at Millennium Pharmaceuticals, Inc., Exelixis, Inc., Thermo Fisher Scientific, Inc., Open Biosystems, Inc., and as a Director-Reagent Products Research & Development at Horizon Discovery Ltd.
Schmitt holds a doctorate degree from the University of Southern California.
Postes actifs de Karin Schmitt
| Sociétés | Poste | Début |
|---|---|---|
Mursla Ltd.
 Mursla Ltd. Information Technology ServicesTechnology Services Mursla Ltd. is a liquid biopsy company based in the UK. The British company uses a novel tech platform called exopheno™ to trace diseases in biofluids via exosomes. Mursla is developing its platform to detect dozens of cancer types with a single blood test, starting with liver cancer surveillance. The company was founded by Pierre Arsène, who has been the CEO since incorporation. | Directeur des opérations | 28/09/2022 |
Anciens postes connus de Karin Schmitt
| Sociétés | Poste | Fin |
|---|---|---|
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/11/2013 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | - |
Open Biosystems, Inc.
 Open Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Open Biosystems, Inc. develops biotechnology solutions. Its products include gene editing, RNA interference, custom RNA synthesis, gene expression (CDNAS and ORFS), transfection and viral packaging. The company was founded by Troy Moore in 2001 and is headquartered in Montgomery, AL. | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Karin Schmitt
| University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Open Biosystems, Inc.
Open Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Open Biosystems, Inc. develops biotechnology solutions. Its products include gene editing, RNA interference, custom RNA synthesis, gene expression (CDNAS and ORFS), transfection and viral packaging. The company was founded by Troy Moore in 2001 and is headquartered in Montgomery, AL. | Health Technology |
Mursla Ltd.
Mursla Ltd. Information Technology ServicesTechnology Services Mursla Ltd. is a liquid biopsy company based in the UK. The British company uses a novel tech platform called exopheno™ to trace diseases in biofluids via exosomes. Mursla is developing its platform to detect dozens of cancer types with a single blood test, starting with liver cancer surveillance. The company was founded by Pierre Arsène, who has been the CEO since incorporation. | Technology Services |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
